share_log

Sernova Has Entered Into A Preclinical Research Collaboration With AstraZeneca To Evaluate The Use Of Sernova's Cell Pouch System In Combination With AstraZeneca's Novel Therapeutic Cells, Deal Terms Were Not Disclosed

Benzinga ·  May 3, 2023 07:31

Under the terms of the collaboration, AstraZeneca will lead and completely fund the development of the cell technologies and pre-clinical activities in conjunction with Sernova. The discovery work is being funded and conducted at AstraZeneca. The preclinical research outcomes will determine the feasibility of potential therapeutic applications and subsequent product development activities between the two companies.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment